Cyrus Jahansouz1, Federico J Serrot1, Brigitte I Frohnert2, Rocio E Foncea3, Robert B Dorman1, Bridget Slusarek1, Daniel B Leslie1, David A Bernlohr3, Sayeed Ikramuddin4. 1. Department of Surgery, University of Minnesota, 420 Delaware St. SE, MMC 195, Minneapolis, MN, 55455, USA. 2. Division of Pediatric Endocrinology, Department of Pediatrics, University of Minnesota, 420 Delaware St. SE, MMC 195, Minneapolis, MN, 55455, USA. 3. Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, 420 Delaware St. SE, MMC 195, Minneapolis, MN, 55455, USA. 4. Department of Surgery, University of Minnesota, 420 Delaware St. SE, MMC 195, Minneapolis, MN, 55455, USA. ikram001@umn.edu.
Abstract
BACKGROUND: Mitochondrial dysfunction in adipose tissue has been implicated as a pathogenic step in the development of type 2 diabetes mellitus (T2DM). In adipose tissue, chronic nutrient overload results in mitochondria driven increased reactive oxygen species (ROS) leading to carbonylation of proteins that impair mitochondrial function and downregulation of key genes linked to mitochondrial biogenesis. In patients with T2DM, Roux-en-Y gastric bypass (RYGB) surgery leads to improvements in glycemic profile prior to significant weight loss. Consequently, we hypothesized that improved glycemia early after RYGB would be paralleled by decreased protein carbonylation and increased expression of genes related to mitochondrial biogenesis in adipose tissue. METHODS: To evaluate this hypothesis, 16 obese individuals were studied before and 7-8 days following RYGB and adjustable gastric banding (AGB). Subcutaneous adipose tissue was obtained pre- and post-bariatric surgery as well as from eight healthy, non-obese individual controls. RESULTS: Prior to surgery, adipose tissue expression of PGC1α, NRF1, Cyt C, and eNOS (but not Tfam) showed significantly lower expression in the obese bariatric surgery group when compared to lean controls (p < 0.05). Following RYGB, but not after AGB, patients showed significant decrease in HOMA-IR, reduction in adipose protein carbonylation, and increased expression of genes linked to mitochondrial biogenesis. CONCLUSIONS: These results suggest that rapid reduction in protein carbonylation and increased mitochondrial biogenesis may explain postoperative metabolic improvements following RYGB.
BACKGROUND:Mitochondrial dysfunction in adipose tissue has been implicated as a pathogenic step in the development of type 2 diabetes mellitus (T2DM). In adipose tissue, chronic nutrient overload results in mitochondria driven increased reactive oxygen species (ROS) leading to carbonylation of proteins that impair mitochondrial function and downregulation of key genes linked to mitochondrial biogenesis. In patients with T2DM, Roux-en-Y gastric bypass (RYGB) surgery leads to improvements in glycemic profile prior to significant weight loss. Consequently, we hypothesized that improved glycemia early after RYGB would be paralleled by decreased protein carbonylation and increased expression of genes related to mitochondrial biogenesis in adipose tissue. METHODS: To evaluate this hypothesis, 16 obese individuals were studied before and 7-8 days following RYGB and adjustable gastric banding (AGB). Subcutaneous adipose tissue was obtained pre- and post-bariatric surgery as well as from eight healthy, non-obese individual controls. RESULTS: Prior to surgery, adipose tissue expression of PGC1α, NRF1, Cyt C, and eNOS (but not Tfam) showed significantly lower expression in the obese bariatric surgery group when compared to lean controls (p < 0.05). Following RYGB, but not after AGB, patients showed significant decrease in HOMA-IR, reduction in adipose protein carbonylation, and increased expression of genes linked to mitochondrial biogenesis. CONCLUSIONS: These results suggest that rapid reduction in protein carbonylation and increased mitochondrial biogenesis may explain postoperative metabolic improvements following RYGB.
Authors: Hongliang Xu; Ann V Hertzel; Kaylee A Steen; Qigui Wang; Jill Suttles; David A Bernlohr Journal: Mol Cell Biol Date: 2015-01-12 Impact factor: 4.272
Authors: Brigitte I Frohnert; Alan R Sinaiko; Federico J Serrot; Rocio E Foncea; Antoinette Moran; Sayeed Ikramuddin; Umar Choudry; David A Bernlohr Journal: Obesity (Silver Spring) Date: 2011-05-19 Impact factor: 5.002
Authors: James M Isbell; Robyn A Tamboli; Erik N Hansen; Jabbar Saliba; Julia P Dunn; Sharon E Phillips; Pamela A Marks-Shulman; Naji N Abumrad Journal: Diabetes Care Date: 2010-04-05 Impact factor: 19.112
Authors: Matthew Stevenson; Ankita Srivastava; Jenny Lee; Christopher Hall; Thomas Palaia; Raymond Lau; Collin Brathwaite; Louis Ragolia Journal: Obes Surg Date: 2021-04-15 Impact factor: 4.129
Authors: R Jokinen; R Rinnankoski-Tuikka; S Kaye; L Saarinen; S Heinonen; M Myöhänen; E Rappou; S Jukarainen; A Rissanen; A Pessia; V Velagapudi; K A Virtanen; E Pirinen; K H Pietiläinen Journal: Int J Obes (Lond) Date: 2017-12-05 Impact factor: 5.095
Authors: R G Vink; N J Roumans; P Fazelzadeh; S H K Tareen; M V Boekschoten; M A van Baak; E C Mariman Journal: Int J Obes (Lond) Date: 2016-11-14 Impact factor: 5.095
Authors: Lane C Porter; Michael P Franczyk; Terri Pietka; Shintaro Yamaguchi; Jonathan B Lin; Yo Sasaki; Eric Verdin; Rajendra S Apte; Jun Yoshino Journal: Am J Physiol Endocrinol Metab Date: 2018-04-10 Impact factor: 4.310
Authors: Gregory N Ruegsegger; Ana L Creo; Tiffany M Cortes; Surendra Dasari; K Sreekumaran Nair Journal: J Clin Invest Date: 2018-08-31 Impact factor: 14.808
Authors: Jessica Sacks; Anny Mulya; Ciaran E Fealy; Hazel Huang; John D Mosinski; Mangesh R Pagadala; Hideharu Shimizu; Esam Batayyah; Philip R Schauer; Stacy A Brethauer; John P Kirwan Journal: Physiol Rep Date: 2018-02
Authors: Ioannis G Lempesis; Rens L J van Meijel; Konstantinos N Manolopoulos; Gijs H Goossens Journal: Acta Physiol (Oxf) Date: 2019-06-02 Impact factor: 6.311
Authors: Birgitta W van der Kolk; Maheswary Muniandy; Dorota Kaminska; Marcus Alvarez; Arthur Ko; Zong Miao; Armand Valsesia; Dominique Langin; Maija Vaittinen; Mirva Pääkkönen; Riikka Jokinen; Sanna Kaye; Sini Heinonen; Kirsi A Virtanen; Daniel P Andersson; Ville Männistö; Wim H Saris; Arne Astrup; Mikael Rydén; Ellen E Blaak; Päivi Pajukanta; Jussi Pihlajamäki; Kirsi H Pietiläinen Journal: J Clin Endocrinol Metab Date: 2021-04-23 Impact factor: 5.958